Fine Mapping and SNP Analysis of Positional Candidates at the Preeclampsia Susceptibility Locus (PREG1) on Chromosome 2

Genome scans in Icelandic, Australian and New Zealand, and Finnish families have localized putative susceptibility loci for preeclampsia/eclampsia to chromosome 2. The locus mapped in the Australian and New Zealand study (designated PREG1) was thought to be the same locus as that identified in the Icelandic study. In both these studies, two distinct quantitative trait locus (QTL) regions were evident on chromosome 2. Here, we describe our fine mapping of the PREG1 locus and a genetic analysis of two positional candidate genes. Twenty-five additional microsatellite markers were genotyped within the 74-cM linkage region defined by the combined Icelandic and Australian and New Zealand genome scans. The overall position and shape of the localization evidence obtained using nonparametric multipoint analysis did not change from that seen previously in our 10-cM resolution genome scan; two peaks were displayed, one on chromosome 2p at marker D2S388 (107.46 cM) and the other on chromosome 2q at 151.5 cM at marker D2S2313. Using the robust two-point linkage analysis implemented in the Analyze program, all 25 markers gave positive LOD scores with significant evidence of linkage being seen at marker D2S2313 (151.5 cM), achieving a LOD score of 3.37 under a strict diagnostic model. Suggestive evidence of linkage was seen at marker D2S388 (107.46 cM) with a LOD score of 2.22 under the general diagnostic model. Two candidate genes beneath the peak on chromosome 2p were selected for further analysis using public single nucleotide polymorphisms (SNPs) within these genes. Maximum LOD scores were obtained for an SNP in TACR1 (LOD = 3.5) and for an SNP in TCF7L1 (LOD = 3.33), both achieving genome-wide significance. However, no evidence of association was seen with any of the markers tested. These data strongly support the presence of a susceptibility gene on chromosome 2p11–12 and substantiate the possibility of a second locus on chromosome 2q23.

[1]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[2]  D. Schlembach Pre-eclampsia--still a disease of theories. , 2003, Fukushima journal of medical science.

[3]  Gonçalo Abecasis,et al.  Positional cloning of a novel gene influencing asthma from Chromosome 2q14 , 2003, Nature Genetics.

[4]  Mark Gurney,et al.  The gene encoding phosphodiesterase 4D confers risk of ischemic stroke , 2003, Nature Genetics.

[5]  L. Almasy,et al.  Novel family‐based approaches to genetic risk in thrombosis , 2003, Journal of thrombosis and haemostasis : JTH.

[6]  Hiroshi Sato,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2002, Nature Genetics.

[7]  C. Bogardus,et al.  Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians , 2002, Diabetologia.

[8]  Laura A Cox,et al.  Identification of candidate genes regulating HDL cholesterol using a chromosomal region expression array. , 2002, Genome research.

[9]  J. Lawrence,et al.  Shared Strategies in Gene Organization among Prokaryotes and Eukaryotes , 2002, Cell.

[10]  M. Adams,et al.  Recent Segmental Duplications in the Human Genome , 2002, Science.

[11]  Steuart Rorke,et al.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness , 2002, Nature.

[12]  Ron Korstanje,et al.  From QTL to gene: the harvest begins , 2002, Nature Genetics.

[13]  Jeanette C Papp,et al.  Detection and integration of genotyping errors in statistical genetics. , 2002, American journal of human genetics.

[14]  J Blangero,et al.  Large upward bias in estimation of locus-specific effects from genomewide scans. , 2001, American journal of human genetics.

[15]  H. Stefánsson,et al.  A genome-wide scan for preeclampsia in the Netherlands , 2001, European Journal of Human Genetics.

[16]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[17]  B. Hogan,et al.  Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Terwilliger,et al.  A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. , 2000, American journal of human genetics.

[19]  Tom H. Lindner,et al.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.

[20]  S. Gardiner,et al.  Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia , 2000, Nature.

[21]  J. Higgins,et al.  The detection, investigation and management of hypertension in pregnancy: full consensus statement , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.

[22]  S Cnattingius,et al.  Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. , 2000, American journal of medical genetics.

[23]  H H Göring,et al.  Linkage analysis in the presence of errors III: marker loci and their map as nuisance parameters. , 2000, American journal of human genetics.

[24]  H H Göring,et al.  Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified. , 2000, American journal of human genetics.

[25]  S. Brennecke,et al.  Pre-eclampsia--still a disease of theories? , 1998, Current opinion in obstetrics & gynecology.

[26]  L Kruglyak,et al.  Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.

[27]  Management of Hypertension in Pregnancy: Executive Summary , 1993 .

[28]  J. Ott Computer-simulation methods in human linkage analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Lindheimer,et al.  Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. , 1981, Medicine.

[30]  L. Chesley,et al.  The Familial Factor in Toxemia of Pregnancy , 1968, Obstetrics and gynecology.

[31]  J. Kere,et al.  Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. , 2003, American journal of human genetics.

[32]  J. Terwilliger On the resolution and feasibility of genome scanning approaches. , 2001, Advances in genetics.